Back to top

gene-editing: Archive

Ekta Bagri

3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025

GeneDx, Twist Bioscience and Wave Life Sciences are emerging as key players in the fast-growing genomics and synthetic biology space.

ILMNNegative Net Change BEAMNegative Net Change WVENegative Net Change CRSPNegative Net Change TWSTNegative Net Change WGSNegative Net Change

Zacks Equity Research

Editas Nominates EDIT-401 as Lead In Vivo Therapy for High Cholesterol

EDIT nominates EDIT-401, a one-time in vivo gene editing therapy, as its lead pipeline candidate to cut the risk of elevated cholesterol.

CRMDPositive Net Change EDITPositive Net Change KNSAPositive Net Change PHARNegative Net Change